Legal Representation
Attorney
Maryam S. Arastu
USPTO Deadlines
Next Deadline
11 days remaining
Examiner's Amendment Completed
Due Date
November 05, 2025
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 21, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 21, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 21, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 21, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 21, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 21, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 21, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 21, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 2, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Oct 2, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005